13.98
+1.68(+13.66%)
Currency In USD
| Previous Close | 12.3 |
| Open | 13.98 |
| Day High | 13.98 |
| Day Low | 13.98 |
| 52-Week High | 14 |
| 52-Week Low | 10.52 |
| Volume | 1 |
| Average Volume | 559 |
| Market Cap | 59.97M |
| PE | -34.1 |
| EPS | -0.41 |
| Moving Average 50 Days | 11.89 |
| Moving Average 200 Days | 11.55 |
| Change | 1.68 |
If you invested $1000 in FutureTech II Acquisition Corp. (FTII) since IPO date, it would be worth $1,403.61 as of August 18, 2025 at a share price of $13.98. Whereas If you bought $1000 worth of FutureTech II Acquisition Corp. (FTII) shares 2 years ago, it would be worth $1,293.25 as of August 18, 2025 at a share price of $13.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance
GlobeNewswire Inc.
Dec 04, 2024 6:35 PM GMT
New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it received an expected deficiency notification letter from the staff (the “Staff”) of The Nasdaq Stock Marke
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
GlobeNewswire Inc.
Sep 20, 2024 6:55 PM GMT
-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase th